L. Tourvieilhe, V. Chamouard, C. Paris, P. Saultier, M. Alessi, N. Giraud, Y. Dargaud, S. Susen
{"title":"在罕见病医疗网络治疗观察站内采用临床药学方法的益处:MHEMO 网络的实例","authors":"L. Tourvieilhe, V. Chamouard, C. Paris, P. Saultier, M. Alessi, N. Giraud, Y. Dargaud, S. Susen","doi":"10.1016/j.phacli.2024.04.281","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":508818,"journal":{"name":"Le Pharmacien Clinicien","volume":"32 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Intérêt d’une démarche de pharmacie clinique au sein des observatoires des traitements des filières de santé maladies rares : exemple de la filière MHEMO\",\"authors\":\"L. Tourvieilhe, V. Chamouard, C. Paris, P. Saultier, M. Alessi, N. Giraud, Y. Dargaud, S. Susen\",\"doi\":\"10.1016/j.phacli.2024.04.281\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":508818,\"journal\":{\"name\":\"Le Pharmacien Clinicien\",\"volume\":\"32 3\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Le Pharmacien Clinicien\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.phacli.2024.04.281\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Le Pharmacien Clinicien","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.phacli.2024.04.281","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Intérêt d’une démarche de pharmacie clinique au sein des observatoires des traitements des filières de santé maladies rares : exemple de la filière MHEMO